Description

2H-Pyrazino[2,1-D]Pyrido[3,2-I][1,5]Benzoxazepine-9-Carboxylic Acid, 11-Cyclopropyl-6-Fluoro-1,3,4,8,11,13,14,14A-Octahydro-8-Oxo- is a complex, high-purity heterocyclic compound with significant potential in advanced pharmaceutical research and development. This molecule is valued for its sophisticated polycyclic structure, which serves as a critical pharmacophore or key synthetic intermediate in the discovery of novel therapeutic agents. It is primarily sought after by pharmaceutical R&D teams, contract research organizations (CROs), and fine chemical manufacturers engaged in developing next-generation medications.

Application

• Pharmaceutical Intermediate: A key building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly for central nervous system (CNS) or anti-infective drug candidates.
• Medicinal Chemistry Research: Used in high-throughput screening and structure-activity relationship (SAR) studies to identify and optimize new lead compounds.
• Process Chemistry Development: Serves as a critical intermediate for scaling up synthetic routes from laboratory to pilot plant and commercial production.
• Reference Standard: Supplied as a high-purity analytical standard for method development, validation, and quality control in regulatory filings.
• Biochemical Tool Compound: Potential use in probing specific biological pathways or enzyme targets in academic and industrial research settings.

Basic Information

Item	Detail
Product Name	2H-Pyrazino[2,1-D]Pyrido[3,2-I][1,5]Benzoxazepine-9-Carboxylic Acid, 11-Cyclopropyl-6-Fluoro-1,3,4,8,11,13,14,14A-Octahydro-8-Oxo-
CAS No.	1271982-15-0
Molecular Formula	C20H18FN3O3
Molecular Weight	367.38 g/mol
Synonyms	11-Cyclopropyl-6-fluoro-1,3,4,8,11,13,14,14a-octahydro-8-oxo-2H-pyrazino[2,1-d]pyrido[3,2-i][1,5]benzoxazepine-9-carboxylic acid; 1271982-15-0; UNII-9V3I6F5M0W; 9V3I6F5M0W; CHEMBL3185225; BDBM50166625; AKOS025147064; ZINC000004218716
EINECS	Contact for details

Quality Control

Every batch of this advanced intermediate is produced under strict quality management systems to ensure consistency and purity for critical research applications. We provide comprehensive Certificates of Analysis (COA) with each shipment, detailing purity, identity, and impurity profiles as determined by HPLC, NMR, and MS. Our quality commitment aligns with the standards expected for GMP-grade intermediates and materials intended for use in regulatory submissions.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This compound is hygroscopic (moisture-sensitive) and should be handled in a dry environment to maintain stability and purity. For long-term storage, consider desiccants or inert atmosphere packaging.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC)	Conforms to reference standard
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.